Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Lung Cancer: the impact of immunotherapy

Roy Herbst, MD, PhD, FACP, FASCO, of Yale University, New Haven, CT, explains the impact of immunotherapy in the treatment of lung cancer at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.